{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:13:08Z","timestamp":1767676388787},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T00:00:00Z","timestamp":1240963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00417-009-1081-y","type":"journal-article","created":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T06:04:37Z","timestamp":1240898677000},"page":"1031-1037","source":"Crossref","is-referenced-by-count":12,"title":["Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up"],"prefix":"10.1007","volume":"247","author":[{"given":"Ciro","family":"Costagliola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Semeraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"Cipollone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"della Corte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario R.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,29]]},"reference":[{"key":"1081_CR1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM200002173420707","volume":"342","author":"SL Fine","year":"2000","unstructured":"Fine SL, Berger JW, Maguire MG, Ho AC (2000) Age-related macular degeneration. N Engl J Med 342:483\u2013492, doi: 10.1056\/NEJM200002173420707","journal-title":"N Engl J Med"},{"key":"1081_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353\u2013364, doi: 10.1016\/S0092-8674(00)80108-7","journal-title":"Cell"},{"key":"1081_CR3","first-page":"2194","volume":"39","author":"B Steen","year":"1998","unstructured":"Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A (1998) Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 39:2194\u20132200","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1081_CR4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archopht.1994.01090160056023","volume":"112","author":"Macular Photocoagulation Study Group","year":"1994","unstructured":"Macular Photocoagulation Study Group (1994) Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: the influence of initial lesion size and initial visual acuity. Arch Ophthalmol 112:480\u2013488","journal-title":"Arch Ophthalmol"},{"key":"1081_CR5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/archopht.1996.01100130396006","volume":"114","author":"Macular Photocoagulation Study Group","year":"1996","unstructured":"Macular Photocoagulation Study Group (1996) Occult choroidal neovascularization: influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol 114:400\u2013412","journal-title":"Arch Ophthalmol"},{"key":"1081_CR6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.81.2.154","volume":"81","author":"M Kliffen","year":"1997","unstructured":"Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PT (1997) Increased expression of angiogenic factors in age-related maculopathy. Br J Ophthalmol 81:154\u2013162, doi: 10.1136\/bjo.81.2.154","journal-title":"Br J Ophthalmol"},{"key":"1081_CR7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"N Ferrara","year":"1997","unstructured":"Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4\u201325, doi: 10.1210\/er.18.1.4","journal-title":"Endocr Rev"},{"key":"1081_CR8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00417-006-0471-7","volume":"245","author":"S Aisenbrey","year":"2007","unstructured":"Aisenbrey S, Ziemssen F, Volker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU (2007) Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245:941\u2013948, doi: 10.1007\/s00417-006-0471-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1081_CR9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/0301-4738.36473","volume":"55","author":"R Kim","year":"2007","unstructured":"Kim R (2007) Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration. Indian J Ophthalmol 55:413\u2013415, doi: 10.4103\/0301-4738.36473","journal-title":"Indian J Ophthalmol"},{"key":"1081_CR10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363\u2013372, doi: 10.1016\/j.ophtha.2005.11.019","journal-title":"Ophthalmology"},{"key":"1081_CR11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","volume":"36","author":"PJ Rosenfeld","year":"2005","unstructured":"Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:331\u2013335","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"1081_CR12","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archopht.125.10.1422","volume":"125","author":"M Rinaldi","year":"2007","unstructured":"Rinaldi M, Dell\u2019Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C (2007) Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Arch Ophthalmol 125:1422\u20131423, doi: 10.1001\/archopht.125.10.1422","journal-title":"Arch Ophthalmol"},{"key":"1081_CR13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ajo.2007.05.025","volume":"144","author":"C Costagliola","year":"2007","unstructured":"Costagliola C, Romano MR, Dellomo R, Cipollone U, Polisena P (2007) Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 144:449\u2013451, doi: 10.1016\/j.ajo.2007.05.025","journal-title":"Am J Ophthalmol"},{"key":"1081_CR14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1006\/jmbi.1999.3192","volume":"293","author":"Y Chen","year":"1999","unstructured":"Chen Y, Wiesmann C, Fuh G et al (1999) Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J Mol Biol 293:865\u2013881, doi: 10.1006\/jmbi.1999.3192","journal-title":"J Mol Biol"},{"key":"1081_CR15","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1016\/S0021-9258(18)35712-0","volume":"267","author":"KA Houck","year":"1992","unstructured":"Houck KA, Leung DW, Rowland AM et al (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031\u201326037","journal-title":"J Biol Chem"},{"key":"1081_CR16","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.ophtha.2007.04.030","volume":"114","author":"PK Kaiser","year":"2007","unstructured":"Kaiser PK, Blodi BA, Shapiro H, Acharya NR, MARINA Study group (2007) Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114:1868\u20131875, doi: 10.1016\/j.ophtha.2007.04.030","journal-title":"Ophthalmology"},{"key":"1081_CR17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ophtha.2006.10.045","volume":"114","author":"DS Boyer","year":"2007","unstructured":"Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR, MARINA Study Group (2007) Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114:246\u2013252, doi: 10.1016\/j.ophtha.2006.10.045","journal-title":"Ophthalmology"},{"key":"1081_CR18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2007.08.012","volume":"144","author":"PK Kaiser","year":"2007","unstructured":"Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, Schneider S, Acharya NR (2007) Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 144:850\u2013857, doi: 10.1016\/j.ajo.2007.08.012","journal-title":"Am J Ophthalmol"},{"key":"1081_CR19","first-page":"361","volume":"19","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Rich RM, Lalwani GA (2006) Ranibizumab: phase III clinical trial results. Ophthalmol Clin North Am 19:361\u2013372","journal-title":"Ophthalmol Clin North Am"},{"key":"1081_CR20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/01.iae.0000244380.34082.67","volume":"26","author":"P Yoganathan","year":"2006","unstructured":"Yoganathan P, Deramo VA, Lai JC, Tibrewala RK, Fastenberg DM (2006) Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration. Retina 26:994\u2013998, doi: 10.1097\/01.iae.0000244380.34082.67","journal-title":"Retina"},{"key":"1081_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/IAE.0b013e31804b3e15","volume":"27","author":"MV Emerson","year":"2007","unstructured":"Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML (2007) Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina 27:439\u2013444, doi: 10.1097\/IAE.0b013e31804b3e15","journal-title":"Retina"},{"key":"1081_CR22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10384-007-0496-4","volume":"52","author":"RV Azad","year":"2008","unstructured":"Azad RV, Khan MA, Chanana B, Azad S (2008) Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population. Jpn J Ophthalmol 52:52\u201356, doi: 10.1007\/s10384-007-0496-4","journal-title":"Jpn J Ophthalmol"},{"key":"1081_CR23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IAE.0b013e31813ffe90","volume":"28","author":"C Incorvaia","year":"2008","unstructured":"Incorvaia C, Campa C, Parmeggiani F, Menzione M, D\u2019Angelo S, Della Corte M, Rinaldi M, Romano M, Dell\u2019omo R, Costagliola C (2008) 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration. Retina 28:289\u2013297, doi: 10.1097\/IAE.0b013e31813ffe90","journal-title":"Retina"},{"key":"1081_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajo.2008.03.014","volume":"146","author":"A Melamud","year":"2008","unstructured":"Melamud A, Stinnett SA, Fekrat S (2008) Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections. Am J Ophthalmol 146:91\u201395, doi: 10.1016\/j.ajo.2008.03.014","journal-title":"Am J Ophthalmol"},{"key":"1081_CR25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00002512-200724080-00003","volume":"24","author":"M Waisbourd","year":"2007","unstructured":"Waisbourd M, Loewenstein A, Goldstein M, Leibovitch I (2007) Targeting vascular endothelial growth factor: a promising strategy for treating age-related macular degeneration. Drugs Aging 24:643\u2013662, doi: 10.2165\/00002512-200724080-00003","journal-title":"Drugs Aging"},{"key":"1081_CR26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/bjo.2007.116616","volume":"91","author":"J Raftery","year":"2007","unstructured":"Raftery J, Clegg A, Jones J, Tan SC, Lotery A (2007) Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness. Br J Ophthalmol 91:1244\u20131246, doi: 10.1136\/bjo.2007.116616","journal-title":"Br J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1081-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-009-1081-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1081-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T16:32:10Z","timestamp":1633365130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-009-1081-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,29]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1007\/s00417-009-1081-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,29]]}}}